These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6104500)

  • 1. Alpha- and beta-adrenoceptor blockade by labetalol in human isolated arteries and veins.
    Thulesius O; Gjöres JE; Berlin E
    Br J Clin Pharmacol; 1980 Jun; 9(6):621-3. PubMed ID: 6104500
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha- and beta-blocking activities of racemates of labetalol.
    Nakagawa Y; Shimamoto N; Nakazawa M; Imai S
    Jpn J Pharmacol; 1980 Oct; 30(5):743-5. PubMed ID: 6110798
    [No Abstract]   [Full Text] [Related]  

  • 3. The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues.
    Brittain RT; Drew GM; Levy GP
    Br J Pharmacol; 1982 Sep; 77(1):105-14. PubMed ID: 6127131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adrenergic blocking agents on response of rabbit arterial and venous strips to catecholamines.
    Lyons BL; Swaine CR
    Proc Soc Exp Biol Med; 1970 Apr; 133(4):1422-5. PubMed ID: 4392491
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of labetalol on the circulatory system (author's transl)].
    Monma Y; Okuoka Y; Kameda H; Ichihara K; Abiko Y; Tanabe T
    Nihon Yakurigaku Zasshi; 1980 May; 76(4):239-54. PubMed ID: 6108907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxant and beta 2-adrenoceptor blocking activities of labetalol, dilevalol, amosulalol and KF-4317 on the rat isolated aorta.
    Doggrell SA
    J Pharm Pharmacol; 1988 Nov; 40(11):812-5. PubMed ID: 2907566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
    Richards DA; Tuckman J; Prichard BN
    Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha- and beta-adrenoceptor blocking actions of labetalol and effects on the myocardial function, coronary circulation and myocardial energy metabolism thereof (author's transl)].
    Katano Y; Takeda K; Nakagawa Y; Hashimoto T; Nakazawa M; Tsukada T; Otorii T; Imai S
    Nihon Yakurigaku Zasshi; 1978 Oct; 74(7):819-32. PubMed ID: 33880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL; McLean K; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labetalol blockade of central alpha- and beta-noradrenergic receptors in rat brain homogenates.
    Devoto P; Stefanini E; Marchisio AM; Vernaleone F; Collu R
    Pharmacol Res Commun; 1980 Feb; 12(2):177-82. PubMed ID: 6104337
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment.
    Monopoli A; Bamonte F; Forlani A; Ongini E; Parravicini L
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):256-63. PubMed ID: 6151824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 1-adrenoceptor blocking activities of bevantolol hydrochloride(NC-1400) and labetalol in rat isolated thoracic aorta--do they distinguish between subtypes?
    Shiraishi K; Moriya M; Miyake N; Takayanagi I
    Gen Pharmacol; 1992 Sep; 23(5):843-5. PubMed ID: 1358746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (+/-)-1-[[2-(3,4-Dimethoxphenyl)ethyl]amino]-3-(3-methylphenoxy)-2- propanol hydrochloride (bevantolol, NC-1400) as a beta 1-selective adrenoceptor blocker with alpha 1-adrenoceptor blocking activity.
    Takayanagi I; Kizawa Y; Iwasaki S; Nakagoshi A
    Gen Pharmacol; 1987; 18(1):87-9. PubMed ID: 2881837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol.
    Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
    Pharmacology; 1989; 39(5):327-36. PubMed ID: 2575762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some complementary data on AH 5158, an inhibitor of both alpha-and beta-adrenoceptors [proceedings].
    Harichaux P; Hary L
    Br J Pharmacol; 1976 Nov; 58(3):412P. PubMed ID: 11020
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacology of labetalol, an alpha- and beta-adrenoceptor blocking agent.
    Blakeley AG; Summers RJ
    Gen Pharmacol; 1978; 9(6):399-402. PubMed ID: 32121
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of labetalol and dilevalol on isolated cardiovascular preparations of the guinea-pig and rat.
    Doggrell SA
    J Pharm Pharmacol; 1992 Dec; 44(12):1001-6. PubMed ID: 1361547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
    Drew GM; Hilditch A; Levy GP
    Clin Exp Hypertens (1978); 1979; 1(5):597-611. PubMed ID: 42517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celiprolol has no direct or indirect relaxing effects in isolated arteries and veins.
    O'Rourke ST; Vanhoutte PM
    J Cardiovasc Pharmacol; 1990 May; 15(5):831-5. PubMed ID: 1692945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.